Minerva (NERV) news
Recent news
Minerva sees leverage rate at about 2.3 times EBITDA by year-end
AInvest Wire · Aug 13, 2026Minerva 2Q net income attributable to holders R$189.6M
Minerva reported a net income attributable to holders of R$189.6 million for the second quarter of the current fiscal year [1]. This figure reflects the company’s financial performance during the period, capturing earnings after all expenses, taxes, and preferred dividends have been accounted for.…
AInvest Wire · Aug 12, 2026Minerva 2Q net revenue R$14.10B, estimated R$14.44B
Minerva reported net revenue of R$14.10 billion for the second quarter, falling short of the estimated R$14.44 billion [1]. The company’s performance reflects a mixed operating environment, with certain segments showing resilience while others faced headwinds. The discrepancy between actual and…
AInvest Wire · Aug 12, 2026Minerva 2Q EBITDA R$1.23B, -5.5% y/y
Minerva Surgical, Inc. reported second-quarter 2023 financial results, with revenue reaching $13.4 million, a 3% increase compared to $13.0 million in the same period of 2022. The growth was driven by a 7% rise in revenue for both the Symphion and Minerva ES product lines, partially offset by a…
AInvest Wire · Aug 12, 2026Minerva 2Q net income R$196.9M, -57% y/y
AInvest Wire · Aug 12, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.